| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-7125(16)30471-0 |
| P698 | PubMed publication ID | 1987446 |
| P2093 | author name string | Baxter JD | |
| P2860 | cites work | The c-erb-A gene encodes a thyroid hormone receptor | Q24293550 |
| Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta | Q24603164 | ||
| A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds | Q24624938 | ||
| A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia | Q24633978 | ||
| Characterization of a thyroid hormone receptor expressed in human kidney and other tissues | Q24651448 | ||
| Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins | Q27686798 | ||
| Characterization of a third human thyroid hormone receptor coexpressed with other thyroid hormone receptors in several tissues | Q28236302 | ||
| Expression of three forms of thyroid hormone receptor in human tissues | Q28275072 | ||
| Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies | Q28282033 | ||
| The c-erb-A protein is a high-affinity receptor for thyroid hormone | Q28282719 | ||
| Species differences in the binding of compounds designed to fit a site of known structure in adult human haemoglobin | Q28325817 | ||
| Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells | Q28360102 | ||
| Protein structure determination in solution by nuclear magnetic resonance spectroscopy | Q30403170 | ||
| Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene | Q33570976 | ||
| T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy | Q33647132 | ||
| Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer | Q33682080 | ||
| Role of the retinoblastoma gene in the initiation and progression of human cancer | Q34246832 | ||
| Clonal composition of benign and malignant human thyroid tumors | Q34255486 | ||
| Do thyroid growth-promoting immunoglobulins exist? | Q68082748 | ||
| Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease | Q68091377 | ||
| A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy | Q68488678 | ||
| Role of non-TSH factors in thyroid cell growth | Q68768885 | ||
| Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma | Q68791282 | ||
| Amiodarone | Q68930408 | ||
| Proto-oncogenes and human cancers | Q69238703 | ||
| Retrovirus-like sequences in Graves' disease: implications for human autoimmunity | Q69369629 | ||
| Low levels of thyroglobulin messenger ribonucleic acid in congenital goitrous hypothyroidism with defective thyroglobulin synthesis | Q69385957 | ||
| Many gene changes found in cancer | Q69400051 | ||
| New AIDS drugs take careful aim | Q69400077 | ||
| Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells | Q69514528 | ||
| Cancer vaccines show promise at last | Q69533085 | ||
| Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism | Q69811572 | ||
| Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues | Q70062417 | ||
| Drug design by the method of receptor fit | Q71330056 | ||
| New Opportunities in Synchrotron X-ray Crystallography | Q81200910 | ||
| A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine le | Q34321338 | ||
| PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas | Q34372878 | ||
| Cellular targets for transformation by the adenovirus E1A proteins | Q34438094 | ||
| Molecular cloning of the thyrotropin receptor | Q34457109 | ||
| Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter | Q34567704 | ||
| Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease | Q35588617 | ||
| Molecular cloning and partial characterization of a new autoimmune thyroid disease-related antigen | Q36483450 | ||
| Antisense RNA and DNA | Q36555016 | ||
| Nasal absorption of insulin: enhancement by hydrophobic bile salts | Q37554143 | ||
| Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells | Q37734603 | ||
| Clinical review 5: Recombinant DNA strategies for determining the molecular basis of endocrine disorders | Q38139459 | ||
| Innovative approaches to plasminogen activator therapy | Q38219654 | ||
| Cell-surface peptidases as modulators of growth and differentiation | Q38364727 | ||
| The significance of T suppressor cells in the development of autoimmunity | Q38373142 | ||
| When the products of oncogenes and anti-oncogenes meet | Q38596880 | ||
| Progress toward human gene therapy | Q38646431 | ||
| Oncogenes, growth factors, and signal transduction | Q38715382 | ||
| Clinical review 3: The clinical use of thyrotropin receptor antibody measurements | Q38724378 | ||
| The causes of autoimmune thyroid disease | Q38756506 | ||
| Oncogenes and tumor-suppressing genes | Q39629828 | ||
| Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts, and misconceptions | Q39685357 | ||
| Targeting of liposomes to tumor cells in vivo | Q39696588 | ||
| Immunotoxins: redirecting nature's poisons | Q39822234 | ||
| Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene | Q41348118 | ||
| Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice | Q41400379 | ||
| Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice | Q41730087 | ||
| Chromatographically purified immunoglobulin G of endemic and sporadic goiter patients stimulates FRTL5 cell growth in a mitotic arrest assay | Q41747197 | ||
| Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells | Q42799828 | ||
| Isolation and transmission of human retrovirus (human t-cell leukemia virus). | Q42823388 | ||
| How cancer cells spread in the body | Q43946651 | ||
| Docking flexible ligands to macromolecular receptors by molecular shape | Q44113013 | ||
| Highly preferred targets for retrovirus integration | Q44445802 | ||
| The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus | Q45845654 | ||
| New targets for human gene therapy | Q45887930 | ||
| Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes | Q46614129 | ||
| Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis | Q46812588 | ||
| Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
| Angiogenesis. Successful growth of tumours. | Q53515258 | ||
| Immunoendocrine interactions and autoimmunity. | Q53864347 | ||
| Thyroid hormone resistance in a large kindred: physiologic, biochemical, pharmacologic, and neuropsychologic studies. | Q54236309 | ||
| Expression of the v-erbA product, an altered nuclear hormone receptor, is sufficient to transform erythrocytic cells in vitro. | Q54348884 | ||
| Deletion of genes on chromosome 1 in endocrine neoplasia | Q57436791 | ||
| Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene | Q64380400 | ||
| P433 | issue | 1 | |
| P921 | main subject | molecular biology | Q7202 |
| P304 | page(s) | 41-59 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Advances in molecular biology. Potential impact on diagnosis and treatment of disorders of the thyroid | |
| P478 | volume | 75 |
Search more.